Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy-Reference-Cited by-同舟云学术

Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

Published:2012-12-01 Issue:12 Volume:97 Page:4454-4463
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Bartalena L.¹,Krassas G. E.²,Wiersinga W.³,Marcocci C.⁴,Salvi M.⁵,Daumerie C.⁶,Bournaud C.⁷,Stahl M.⁸,Sassi L.¹,Veronesi G.⁹,Azzolini C.¹⁰,Boboridis K. G.¹¹,Mourits M. P.¹²,Soeters M. R.³,Baldeschi L.¹²,Nardi M.¹³,Currò N.¹⁴,Boschi A.¹⁵,Bernard M.¹⁶,von Arx G.¹⁷,

Affiliation:

1. Department of Clinical and Experimental Medicine (L.Bar., L.Sa.), Research Center in Epidemiology

2. Department of Endocrinology, Diabetes, and Metabolism (G.E.K.), Panagia General Hospital, 55132 Thessaloniki, Greece

3. Department of Endocrinology and Metabolism (W.W., M.R.S.), Academic Medical Center

4. Department of Endocrinology and Metabolism (C.M.), 56127 Pisa, Italy

5. Endocrinology (M.Sa.), Fondazione IRCCS Ca' Granda, 20122 Milan, Italy

6. Département de Médecine Interne (C.D.), B-1348 Brussels, Belgium

7. Department of Endocrinology and Nuclear Medicine (C.B.) and Neuro-Ophthalmology Outpatient Clinics

8. Department of Endocrinology and Metabolism (M.St.), Kantonsspital

9. Preventive Medicine (G.V.), Department of Clinical and Experimental Medicine

10. Department of Surgical and Morphological Sciences (C.A.), Section of Ophthalmology, University of Insubria, 21100 Varese, Italy

11. University Department of Ophthalmology (K.G.B.), Ahepa Hospital, 54636 Thessaloniki, Greece

12. Academic Medical Center (M.P.M., L.Bal.), 1105 AZ Amsterdam, The Netherlands

13. Department of Neuroscience (M.N.), Section of Ophthalmology, University of Pisa, 56127 Pisa, Italy

14. Department of Ophthalmology (N.C.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, 20132 Milan, Italy

15. Department of Ophthalmology (A.B.), Université Catholique de Louvain, B-1348 Brussels, Belgium

16. GHE-Hospices Civils de Lyon and Lyon 1 University (M.B.), Lyon, France; 69622 Lyon, France

17. Department of Ophthalmology (G.v.A.), Interdisziplinaires Zentrum fur Endokrine Orbitopathie, CH-4600 Olten, Switzerland

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/97/12/4454/9046536/jcem4454.pdf

Reference34 articles.

1. Graves' ophthalmopathy.;Bahn;N Engl J Med,2010

2. Pathogenesis of Graves' orbitopathy: a 2010 update.;Smith;J Endocrinol Invest,2010

3. Management of Graves' ophthalmopathy: reality and perspectives.;Bartalena;Endocr Rev,2000

4. Quality of life;Wiersinga,2010

5. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey.;Estcourt;Eur J Endocrinol,2009

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of intravenous methylprednisolone on serum antibody levels in thyroid eye disease;British Journal of Ophthalmology;2024-09-09

2. A Biologic With Otologic Consequences: Analysis of Hearing Loss and Teprotumumab Using the FDA Adverse Event Reporting System;Otology & Neurotology;2024-09

3. Long-Term Outcomes following Teprotumumab for Thyroid Eye Disease;Clinical Thyroidology®;2024-08-01

4. Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review With Meta-analysis;The Journal of Clinical Endocrinology & Metabolism;2024-07-30

5. Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials;Thyroid®;2024-07-01